Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
RICHARD ANDREWS President and CEO of CartoCanada Inc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
RICHARD ANDREWS President and CEO of CartoCanada Inc
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Silver One Resources: Uncovering Untapped Potential in Nevada and Mexico
00:10:00
Alpha Omega Wealth: Proven Strategies for Private Wealth Management | Joe Pantozzi , President , Alpha Omega Wealth Management LLC.
00:10:00
Explore the technical aspects of Bitcoin, including insights into network maintenance by developers, facilitated by Brink through grants and fellowships support.
00:10:00
Tom Metzold, Co-Director of Municipal Investments at Eaton Vance Management, comments on President Obama's "America" in a single line.
00:10:00
Insights from a CEO on Educating Physicians and Recognizing Diagnostic Challenges | Dr. Arndt Rolfs, CEO, Centogene NV.
00:10:00
Paul Reilly, CEO of Raymond James, Discusses Economic Outlook and Company Strategy Amidst Uncertain Times| Paul Reilly, CEO , Raymond James.
00:10:00
Markus Meijer on Meyer Bergman's Commitment and Strategy | Marcus Mayer, CEO, Meyer Bergman.
00:10:00
CEO of Convergenze SpA, Discusses Competitive Strategies at The European House-Ambrosetti Forum | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
John Michael Wisbey Chairman/CEO, of International Lithium Corp.
00:10:00
Reflections on the 1960s: Ideology, Protest, and Cultural Transformation|William F. Buckley
00:10:00
Stephen Siderow, co-founder of BlueMountain Capital Management LLC, discusses his investment strategy focused on risk management and diversified portfolios.|Andrew Todd Feldstein is the Blue Mountain Capital Management's CEO
00:10:00
TJ Rodgers: Capitalism, Environmentalism, and Corporate Responsibility|T. J. Rodgers